1. Hauser R, Almquist A, and Kallinen L. Occult failure of implantable cardioverter defibrillator systems. PACE, 1999;22(6(11)):A-141.
2. Poole JE, Bardy GH, Dolack GL, et al. Serial defibrillation threshold measures in man: a prospective controlled study. J Cardiovasc Electrophysiol, 1995; 6 (1): 19–25.
3. Guamieri T, Levine JH, Veltri EP, et al. Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator. Am 1 Cardiol, 1987, 60 (13): 1061–1064.
4. Huang SK, Tan de Guzman WL, Chenarides JG, et al. Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator. Am Heart J, 1991; 122 (3 Pt 1): 720–727.
5. Jung W, Manz M, and Luderitz B. Effects of antiarrhythmic drugs on defibrillation threshold in patients with the implantable cardioverter defibrillator. Pacing Clin Electrophysiol, 1992; 15 (4 Pt 3): 645–648.